Literature DB >> 7604037

A kinase associated with chromatin that can be activated by ligand-p185c-Neu or epidermal growth factor-receptor interactions.

A Samanta1, M I Greene.   

Abstract

Some growth factors transduce positive growth signals, while others can act as growth inhibitors. Nuclear signaling events of previously quiescent cells stimulated with various growth factors have been studied by isolating the complexed chromatin-associated proteins and chromatin-associated proteins. Signals from the plasma membrane are integrated within the cells and quickly transduced to the nucleus. It is clear that several growth factors, such as epidermal growth factor, transforming growth factor alpha (but not transforming growth factor beta), and platelet-derived growth factor, utilize similar intracellular signaling biochemistries to modulate nucleosomal characteristics. The very rapid and consistent phosphorylation of nuclear p33, p54, and low molecular mass proteins in the range of 15-18 kDa after growth factor stimulation implies that there is a coordination and integration of the cellular signaling processes. Additionally, phosphorylation of p33 and some low molecular mass histones has been found to occur within 5 min of growth factor treatment and to reach a maximum by 30 min. In this study, we report that Neu receptor activating factor also utilizes the same signaling mechanism and causes p33 to become phosphorylated. In addition, both the tumor promoter okadaic acid (which inhibits protein phosphatases 1 and 2A) and phorbol ester (phorbol 12-tetradecanoate 13-acetate) stimulate phosphorylation of p33, p54, and low molecular mass histones. However, transforming growth factor beta, which is a growth inhibitor for fibroblasts, fails to increase p33 phosphorylation. In general, p33 phosphorylation patterns correspond to positive and negative mitogenic signal transduction. p33 isolated from the complexed chromatin-associated protein fraction appears to be a kinase, or tightly associated with a kinase, and shares antigenicity with the cell division cycle-dependent Cdk2 kinase as determined by antibody-dependent analysis. The rapid phosphorylation of nucleosomal proteins may influence sets of early genes needed for the induction and progression of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7604037      PMCID: PMC41562          DOI: 10.1073/pnas.92.14.6582

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.

Authors:  D B Weiner; J Liu; J A Cohen; W V Williams; M I Greene
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.

Authors:  F López-Casillas; S Cheifetz; J Doody; J L Andres; W S Lane; J Massagué
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

Review 3.  Cyclins and cancer.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

Review 4.  Mannose 6-phosphate receptors and lysosomal enzyme targeting.

Authors:  N M Dahms; P Lobel; S Kornfeld
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

5.  Cyclin synthesis drives the early embryonic cell cycle.

Authors:  A W Murray; M W Kirschner
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

6.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II.

Authors:  T W Sturgill; L B Ray; E Erikson; J L Maller
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

7.  Characterization of a neu/c-erbB-2 protein-specific activating factor.

Authors:  K Dobashi; J G Davis; Y Mikami; J K Freeman; J Hamuro; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF.

Authors:  D Arion; L Meijer; L Brizuela; D Beach
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

9.  Induction of proto-oncogene JUN/AP-1 by serum and TPA.

Authors:  W W Lamph; P Wamsley; P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

10.  Molecular cloning of syndecan, an integral membrane proteoglycan.

Authors:  S Saunders; M Jalkanen; S O'Farrell; M Bernfield
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.